Menu Search
Equities

Sysmex Corp

6869N:MEX

Sysmex Corp

Actions
  • Price (MXN)289.82
  • Today's Change-111.52 / -27.79%
  • Shares traded3.70k
  • 1 Year change-3.65%
  • Beta--
Data delayed at least 20 minutes, as of Aug 10 2023 12:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.

  • Revenue in JPY (TTM)491.29bn
  • Net income in JPY53.45bn
  • Incorporated1968
  • Employees10.04k
  • Location
    Sysmex Corp1-5-1, Wakinohama Kaigandori, Chuo-kuKOBE-SHI 651-0073JapanJPN
  • Phone+81 782650500
  • Fax+81 782650524
  • Websitehttps://www.sysmex.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		6869:TYO since
announced		Transaction
value
Megakaryon CorpDeal completed20 Dec 202320 Dec 2023Deal completed22.64%--
Data delayed at least 20 minutes, as of Nov 25 2024 05:56 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.